1pm - 1:15pm

Welcome & Opening Remarks

• Kathie Simpson, RN, BSN, CACPN; NOAP President; Irwin, Pennsylvania
• Welcome Slides
  

1:15pm - 1:25pm

Meet Affinity Empowering, Platinum Sponsor (5 min)

1:25pm - 2:40pm

CE: 1.25

Session 1. Medication Assisted Treatment for Opioid Addiction Among Safety-Sensitive Workers: What Lurks Beneath the Controversy?  

• Presentation Handout
• Chris Bundy, MD, MPH; Executive Medical Director, Washington Physicians Health Program; Seattle, Washington
  

Objectives:

1. State the risks, benefits and alternatives of opioid agonist treatment among safety-sensitive workers.
   
2. Analyze opioid agonist treatment for safety-sensitive workers from the perspectives of individualized treatment vs. population management.
   
3. Discuss how the opioid agonist controversy may be influenced by underlying attitudes and beliefs about the goals of health monitoring.

2:40pm - 2:45pm

Meet USDTL, Gold Sponsor (1 min)

2:45pm - 3:45pm

CE: 1.00

Session 2. Wholehearted Journey to Ethics for Healthcare Professionals

• Presentation Handout
• Maeve O'Neill, MEd, LCDC, LPC-S, CHC, CDWF/CDTLF; Chief Regulatory Officer, Rogers Behavioral Health; Dallas, Texas

Objectives:

1. Recognize ethical issues and apply concepts to self, team organizational culture.
   
2. Demonstrate understanding of wholehearted concepts applied to Ethics.
   
3. Plan use of concepts in daily work.

3:45pm - 4pm

1pm - 1:10pm

Welcome & Opening Remarks

• Suzanne Alunni-Kinkle, MSN, RN, CARN; NOAP 2021 Conference Co-Chair

1:10pm - 1:20pm

Meet FSSolutions, Platinum Sponsor (5 min)

1:20pm - 2:50pm

CE: 1.50

Session 3. FSPHP Guidelines for 2021

• Presentation Handout
• Paul H. Earley, MD, DFASAM; Georgia Professionals Health Program, Inc.; Atlanta, Georgia

Objectives:

1. Describe how past perspectives on addiction have contributed to our current misperceptions about addiction care.
   
2. List current standards for addiction care.
   
3. Describe current FSPHP efforts to standardize treatment and monitoring approached to addiction treatment.

2:50pm - 2:55pm

Meet Focused Solutions Advocate, Gold Sponsor (1 min)

2:55pm - 3:55pm

CE: 1.00

Session 4. Adaptations to substance use disorder monitoring by physician health programs in response to COVID-19

• Presentation Handout
  
• Alexis Polles, MD; Medical Director and CEO; Florida Professionals Resource Network; Fernandina Beach, Florida
  

Objectives:

1. Describe why recommendations for evaluation, treatment, and monitoring of healthcare workers are more stringent than in the general population.
   
2. Describe 3 ways in which monitoring has evolved during the COVID-19 pandemic.
3. Discuss how traumatic events including acute and chronic aspects of COVID-19 affect healthcare workers.

3:55pm - 4pm

Wrap Up

1pm - 1:10pm

Welcome & Opening Remarks

• Andrew Haviland, NOAP 2021 Conference Committee
  RAMP; Ewing, New Jersey
  

1:10pm - 1:20pm

Meet UF Health, Florida Recovery Center, Platinum Sponsor (5 min)

1:20pm - 2:35pm

CE: 1.25

• Presentation Handout
• The NPDB - Practitioner's Guide to the NPDB Infographic
• The NPDB - Self-Query Infographic
• Dispute Guide
• Anastasia Timothy, MD, MPH; National Practitioner Data Bank; Washington, DC
  
• Paul Lotterer, JD; National Practitioner Data Bank; Washington, DC

Objectives:

1. Understand the laws, regulations, and main components of the NPDB.
2. Define NPDB querying and reporting requirements and apply these requirements to a variety of scenarios.
   
3. Learn how to self-query.
   
4. Learn how to enter a narrative in a report.
   

2:35pm - 2:40pm

Speaker Introduction

2:40pm - 3:55pm

CE: 1.25

Session 6. Considerations in the Treatment of LGBTQ Populations

• Presentation Handout
• Melissa Lee Warner, MD; Director of Professionals Programming, The Farley Center; Williamsburg, Virginia

Objectives:

1. Define various sexual identity and gender designations.
   
2. Develop proficiency with patient pronouns and interviewing.
   
3. Understand factors to consider in treating the LGBTQ population.

3:55pm - 4pm

1pm - 1:15pm

Welcome & Opening Remarks

• Myrtle Greene, PhD, LMHC, CAP, ICADC; NOAP President-Elect
  Intervention Project for Nurses; Jacksonville Beach, Florida

1:15pm - 2:30pm

CE: 1.25

Session 7. Program Sharing

• Presentation Handout
• Myrtle Greene, PhD, LMHC, CAP, ICADC; Intervention Project for Nurses; Jacksonville Beach, Florida
  

Objectives:

1. Compare and contrast the different types of ATD programs in the following areas: relationship to the disciplining authority, funding of operational costs, number of participants monitored, staffing ratios and number of disciplines monitored.
   
2. Identify operational policies and procedures staff currently views as best practices.
   
3. Discuss current challenges programs are encountering as a result of COVID-19.

2:30pm - 2:35pm

Meet the Gold Sponsor, Acadia Healthcare (1 min) & Speaker Introduction

2:35pm - 3:50pm

CE: 1.25

Session 8. Walking the Edge: Passion and Pathology in Recovery

• Presentation Handout
• Sherry Young, PhD, CSAT; RightFit Consulting
  

Objectives:

1. Identify "the edge," those precarious points where passion and pathology walk a fine line in recovery, service, and self-care.
2. Name ways to cultivate care, containment, and spiritual resourcing.

3:50pm - 4pm

1pm - 2pm

Business Meeting

• Business Meeting Minutes from 2019 (pdf)
  
• Presentation Slides

1. Call to Order
2. Approval of the Agenda
3. Approval of the Prior Meeting Minutes
4. Accomplishments 2019-2021
5. Membership & Treasurers Report - Robert Ranieri and John Furman
6. Introduction of New & Returning Board Members
7. Transfer of Leadership
8. Bylaws committee report - Shane Moes
9. Research committee report - John Furman
10. Membership & 2022 Conference Committee
11. In Memoriam
12. NOAP 2022, 2023 Conferences
13. New/Old Business/Adjourn

2pm - 2:15pm

Meet RecoveryTrek, Platinum Sponsor (5 min)

2:15pm - 4pm

CE: 1.75

Session 9. MRO / Toxicology Panel Discussion

1. Urinary Auto Brewery Syndrome Article
2. Auto Brewery Syndrome Undiagnosed Medical Condition Article
3. Oral Fluid Testing
   
4. Evidence for Medical Marijuana Handout
5. Dilution Concerns for Recovery Monitoring
6. Tips to Avoid Dilute Urine Specimens
7. Dilution Concerns in Recovery Monitoring
8. Dilute Urine Specimens - Follow up
9. MRO Review in RMS

• Moderator: Kathie Simpson, RN, BSN, CACPN
• Joe Jones, PhD, USDTL; Des Plaines, Illinois
• Donna Smith, PhD, EdD; RecoveryTrek; Virginia Beach, Virginia
• Anthony Costantino, PhD, F-ABFT; Costantino Consulting Services, Inc.; Blue Bell, Pennsylvania
• James Ferguson, DO, DFASAM, C-MRO; FSSolutions; Chalfont, Pennsylvania
• Barry Lubin, MD, FASAM, MRO; Affinity Online Solutions; Vienna, Virginia

Objectives:

1. Describe procedures and accuracy of oral fluid testing.
2. Verbalize indications and processes for workplace testing.
3. Recognize the importance of PEth testing as a component of monitoring.
4. Describe the process for collecting and analyzing a hair and nail analysis.
5. Explain how to address a positive Kratom result.
6. Describe appropriate levels for prescribed Gabapentin, Lyrica and Suboxone.
7. Describe the effects of over the counter products in relation to positive screen for EtG/EtS.
   

4pm

Wrap Up

1pm - 1:05pm

Welcome & Opening Remarks

• Meg McGauley
  NOAP Board of Directors
  

1:05pm - 1:15pm

Speaker Introduction

1:15pm - 2:15pm

CE: 1.00

Session 10. Gambling Disorder: The Hidden Addiction

• Presentation Handout
• Jeffrey P. Wasserman, JD, CPRS, ICGC-I; Judicial Outreach and Development Director, Delaware Council on Gambling Problems, Inc.; Wilmington, Delaware

Objectives:

1. Recognize the screening and diagnostic criteria for gambling disorder and who is at risk.
   
2. Understand the connection between gambling disorder and substance use disorders.
   
3. Appreciate the harms unique to gambling disorder through the speaker’s lived experience.
   
4. Identify best practices for prevention and treatment of gambling disorder.

2:30pm - 2:35pm

2:35pm - 3:50pm

CE: 1.25

Session 11. Evaluating and Addressing Depression and Suicide in the Medical/Licensed Professional

• Presentation Handout
• Lantie Jorandby, MD; Chief Medical Officer, Lakeview Health; Jacksonville, Florida

Objectives:

1. Review the unique risks of depression and suicide for medical professionals.
   
2. Understand how these risks affect patient care.
   
3. Discuss effective treatment interventions for medical professionals.

3:50pm - 4pm

1pm - 1:05pm

Welcome & Opening Remarks

• John Furman, PhD, MSN, COHN-S; NOAP Treasurer
  Dept of Health - WA Health Professional Services (WHPS); Olympia, Washington
  
  

1:05pm - 1:15pm

Meet the Platinum Sponsor, Geisinger Marworth Treatment Center (5 min)

1:15pm - 2:30pm

CE: 1.25

Session 12. Study Results and Implications: Outcomes of Substance Use Disorder Monitoring Programs

• Presentation Handout
• Richard A. Smiley, MS, MA; National Council of State Boards of Nursing (NCSBN); Chicago, Illinois

Objectives:

1. Identify the purposes and methods of the NCSBN Outcomes of Substance Use Disorder (SUD) Monitoring Programs.
   
2. Identify the results of the NCSBN Outcomes of Substance Use Disorder (SUD) Monitoring Programs.
   
3. Identify the factors of the Substance Use Disorder (SUD) Monitoring Programs which are most positively associated with program completion.

2:30pm - 2:35pm

2:35pm - 3:35pm

CE: 1.00

Session 13. Mindfulness and Spiritual Awakening

• Presentation Handout
• James “Wolf” Yoxall, CSC, Ordained Minister, MA; Spiritual/Wellness Director; Pavillon; Mill Spring, North Carolina

Objectives:

1. Participants will come to understand the importance of mindfulness practices and spiritual awareness to help free themselves from stress and apply better self-care in their daily lives.
2. Participants will engage in practical exercises of mindfulness and ways of connecting to their spiritual belief that will enhance their overall wellbeing. These exercises will be structured to take back to their work place or home to enhance their over-all sense of wellbeing.